Resistell News:

Nature Communications publishes Resistell's groundbreaking AST platform

Nature Communications publishes Resistell's groundbreaking AST platform
Resistell News:

Nature Communications publishes Resistell's groundbreaking AST platform

Resistell, an EPFL spin-off developing rapid phenotypic antibiotic susceptibility testing (AST) solutions, announces the peer-reviewed article in the Nature Communications journal. The publication marks the completion of the company’s technology validation stage and showcases the potential of the Resistell nanomotion technology platform as a diagnostic in the fight against antimicrobial resistance (AMR).

More
Nature Communications publishes Resistell's groundbreaking AST platform

Latest news

Resistell at CNN Money
15th April 2019

Resistell at CNN Money

Danuta selected as top four up-and-coming entrepreneurs who made the best pitch at the annual Startup Champions Seed Night. Watch us on CNN Money and see how we will take our startup to the next level.
More
11th April 2019

Join us at ECCMID 2019 in Amsterdam, 13 - 16 April 2019

We invite you to meet us in Amsterdam at ECCMID 2019 (13 - 16 April 2019) and learn more about our rapid AST approach, see the product and discuss the future cooperations. Meet us any time at the booth 1.107!
More
Resistell presents rapid AST startup at D.Day 2019 at CHUV
10th April 2019

Resistell presents rapid AST startup at D.Day 2019 at CHUV

D.Day 2019 – Discover what your neighbours are working on!
More
iMedPub Journals about Resistell's rapid AST
10th April 2019

iMedPub Journals about Resistell's rapid AST

“This process is one of the most rapid methods in this review and can be used to develop quantitative anti-biograms”, Puttaswamy et al., 2018, Archives of Clinical Microbiology, 9:3, 83 https://doi.org/10.4172/1989-8436.100083
More
2nd April 2019

CHUV on the list of the 10 Best Hospitals in the World

Well done to all our colleagues from CHUV Hospital, recently listed in the top 10 best hospitals in the world. Resistell is proud to develop the rapid AST with the support of CHUV Hospital. Thank you and congratulations!
More